G-Quadruplex Clips for Dopamine Regulation via Nanoparticle Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current strategies for modulating dopamine production in neurological disorders, such as Parkinson's disease, face challenges due to limited capability in altering the stability of G-quadruplexes (GQs) within the TH promoter and poor selectivity, along with difficulties in targeted delivery of nucleic acid therapeutics across the blood-brain barrier and cellular recognition.
Innovation Solution
Development of rationally designed DNA GQ Clips complementary to specific segments of the TH promoter to modulate GQ formation, combined with a nanoparticle delivery system using a TrkB peptide aptamer for targeted delivery to dopaminergic neurons, enhancing bioavailability and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If small molecule ligands are used to target GQs in the TH promoter, then transcription can be modulated, but selectivity is poor and capability to alter GQ stability is limited
Solution Approach 1:
The patent introduces GQ Clips as intermediary molecules that specifically bind to G-quadruplex structures in the TH promoter. These Clips act as mediators between the therapeutic goal (modulating transcription) and the target (GQ structures), providing both stability alteration and sequence-specific recognition that small molecules cannot achieve alone
Solution Approach 2:
The patent creates a composite therapeutic approach by combining GQ Clips (nucleic acid-based targeting molecules) with nanoparticle delivery systems. This composite strategy integrates the specific GQ-binding capability of Clips with the enhanced delivery and stability properties of nanoparticles, overcoming the limitations of either approach alone
2Productivity
If nucleic acid therapeutics are delivered systemically, then they can reach target genes, but they fail to cross the blood-brain barrier and achieve cellular recognition
Solution Approach 1:
The patent employs nanoparticles as intermediary carriers that facilitate the transport of GQ Clips across the blood-brain barrier. These nanoparticles act as mediators that protect the nucleic acid therapeutics from degradation and enable their passage through biological barriers that would otherwise prevent access to the target
Solution Approach 2:
The patent modifies the physical and chemical parameters of the therapeutic delivery system by encapsulating GQ Clips in nanoparticles. This parameter change (from free nucleic acid to nanoparticle-encapsulated form) fundamentally alters the delivery properties, enabling blood-brain barrier penetration and cellular uptake while maintaining the therapeutic function
3Reliability
If free DNA molecules are used to target GQs, then they can bind to the TH promoter, but they have poor bioavailability and stability in vivo
Solution Approach 1:
The patent uses nanoparticle shells to encapsulate and protect the GQ Clip DNA molecules. This flexible protective shell shields the DNA from enzymatic degradation and environmental factors, significantly improving stability and bioavailability while allowing the DNA to maintain its GQ-binding functionality
Solution Approach 2:
The patent creates a composite structure where the GQ Clip DNA is integrated with the nanoparticle matrix. This composite material combines the specific binding properties of DNA with the protective and delivery-enhancing properties of the nanoparticle, resulting in a therapeutically viable formulation with improved stability
Data Source
AI summary
Novel DNA molecule-based compositions and methods for delivery to target cells provide modulation of target G-quadruplex formation in the tyrosine hydroxylase (TH) promoter and allow for enhancement or repressing of specific G-quadruplexes that in turn regulate tyrosine hydroxylase transcription and catecholamine production, specifically dopamine. Use of the DNA-molecule-based compositions in treatment of neurological diseases and disorders is facilitated through a nanoparticle-based delivery system.